Jane Osbourn is the founder of Alchemab Therapeutics. Alchemab Therapeutics has raised $82M, latest Series A $82M (2021). Biotech · London, UK.
Jane Osbourn is the founder of Alchemab Therapeutics. Alchemab Therapeutics operates in Biotech and is based in London, UK. Alchemab Therapeutics has raised $82M, latest Series A $82M (2021). Backers on record include Houman Ashrafian, Nikola Trbovic, SV Health Investors.
This founder profile draws on disclosed rounds, filings and investor records in the StartupFundraising database and is updated as new funding is recorded. Founders raising now use profiles like this one to study comparable Biotech journeys in London — who backed them, at what stage, and how much they raised.
Full founder directory · Investor directory · Company funding database · Fundraising library